S00–T88: Injury, Poisoning and Certain Other Consequences of External Causes
Chapter 19 of ICD-10-CM 2027, 54,325 codes in 24 blocks.
Advertisements
Codes in this chapter
All codesBillable only54,325 results
- T80.40Rh incompatibility reaction due to transfusion of blood or blood products, unspecified
- T80.40XARh incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter
- T80.40XDRh incompatibility reaction due to transfusion of blood or blood products, unspecified, subsequent encounter
- T80.40XSRh incompatibility reaction due to transfusion of blood or blood products, unspecified, sequela
- T80.41Rh incompatibility with hemolytic transfusion reaction
- T80.410Rh incompatibility with acute hemolytic transfusion reaction
- T80.410ARh incompatibility with acute hemolytic transfusion reaction, initial encounter
- T80.410DRh incompatibility with acute hemolytic transfusion reaction, subsequent encounter
- T80.410SRh incompatibility with acute hemolytic transfusion reaction, sequela
- T80.411Rh incompatibility with delayed hemolytic transfusion reaction
- T80.411ARh incompatibility with delayed hemolytic transfusion reaction, initial encounter
- T80.411DRh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter
- T80.411SRh incompatibility with delayed hemolytic transfusion reaction, sequela
- T80.419Rh incompatibility with hemolytic transfusion reaction, unspecified
- T80.419ARh incompatibility with hemolytic transfusion reaction, unspecified, initial encounter
- T80.419DRh incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter
- T80.419SRh incompatibility with hemolytic transfusion reaction, unspecified, sequela
- T80.49Other Rh incompatibility reaction due to transfusion of blood or blood products
- T80.49XAOther Rh incompatibility reaction due to transfusion of blood or blood products, initial encounter
- T80.49XDOther Rh incompatibility reaction due to transfusion of blood or blood products, subsequent encounter
- T80.49XSOther Rh incompatibility reaction due to transfusion of blood or blood products, sequela
- T80.5Anaphylactic reaction due to serum
- T80.51Anaphylactic reaction due to administration of blood and blood products
- T80.51XAAnaphylactic reaction due to administration of blood and blood products, initial encounter
- T80.51XDAnaphylactic reaction due to administration of blood and blood products, subsequent encounter
- T80.51XSAnaphylactic reaction due to administration of blood and blood products, sequela
- T80.52Anaphylactic reaction due to vaccination
- T80.52XAAnaphylactic reaction due to vaccination, initial encounter
- T80.52XDAnaphylactic reaction due to vaccination, subsequent encounter
- T80.52XSAnaphylactic reaction due to vaccination, sequela
- T80.59Anaphylactic reaction due to other serum
- T80.59XAAnaphylactic reaction due to other serum, initial encounter
- T80.59XDAnaphylactic reaction due to other serum, subsequent encounter
- T80.59XSAnaphylactic reaction due to other serum, sequela
- T80.6Other serum reactions
- T80.61Other serum reaction due to administration of blood and blood products
- T80.61XAOther serum reaction due to administration of blood and blood products, initial encounter
- T80.61XDOther serum reaction due to administration of blood and blood products, subsequent encounter
- T80.61XSOther serum reaction due to administration of blood and blood products, sequela
- T80.62Other serum reaction due to vaccination
- T80.62XAOther serum reaction due to vaccination, initial encounter
- T80.62XDOther serum reaction due to vaccination, subsequent encounter
- T80.62XSOther serum reaction due to vaccination, sequela
- T80.69Other serum reaction due to other serum
- T80.69XAOther serum reaction due to other serum, initial encounter
- T80.69XDOther serum reaction due to other serum, subsequent encounter
- T80.69XSOther serum reaction due to other serum, sequela
- T80.8Other complications following infusion, transfusion and therapeutic injection
- T80.81Extravasation of vesicant agent
- T80.810Extravasation of vesicant antineoplastic chemotherapy